|
Intramuscular Adaptations and MHC mRNA Expression |
|||
| Marker |
AA (n = 15) |
PLA (n = 16) |
Significance |
|
|
|||
| Total protein (μg·g-1) |
Group: 0.92 |
||
| Day 0 |
7.5 ± 4.5 |
6.6 ± 3.8 |
Time: 0.28 |
| Day 50 |
7.0 ± 4.5 |
8.2 ± 4.3a,b |
G × T: 0.05 |
| FP receptor (INT·mm2·mg-1) |
Group: 0.63 |
||
| Day 0 |
1,929 ± 1,395 |
2,253 ± 1,309 |
Time: 0.13 |
| Day 50 |
2,425 ± 1,746 |
2,518 ± 992 |
G × T: 0.64 |
| EP3 receptor (INT·mm2·mg-1) |
Group: 0.55 |
||
| Day 0 |
5,990 ± 3,563 |
6,854 ± 3,287 |
Time: 0.11 |
| Day 50 |
7,149 ± 3,383 |
7,529 ± 2,791 |
G × T: 0.66 |
| MHC I protein (ng·ml-1) |
Group: 0.78 |
||
| Day 0 |
187.8 ± 180.7 |
172.8 ± 123.0 |
Time: 0.64 |
| Day 50 |
176.3 ± 104.4 |
164.3 ± 126.6 |
G × T: 0.96 |
| MHC IIa protein (ng·ml-1) |
Group: 0.84 |
||
| Day 0 |
184.4 ± 217.1 |
156.9 ± 84.5 |
Time: 0.009 |
| Day 50 |
305.0 ± 366.3 |
295.8 ± 328.5 |
G × T: 0.84 |
| MHC IIx protein (ng·ml-1) |
Group: 0.55 |
||
| Day 0 |
128.7 ± 79.1 |
133.6 ± 83.5 |
Time: 0.23 |
| Day 50 |
103.9 ± 68.2 |
131.9 ± 81.7 |
G × T: 0.29 |
| MHC I mRNA |
Group: 0.45 |
||
| Day 0 |
0.69 ± 0.16 |
0.68 ± 0.14 |
Time: 0.70 |
| Day 50 |
0.64 ± 0.07 |
0.71 ± 0.15 |
G × T: 0.14 |
| MHC IIa mRNA |
Group: 0.32 |
||
| Day 0 |
0.66 ± 0.12 |
0.66 ± 0.14 |
Time: 0.55 |
| Day 50 |
0.63 ± 0.07 |
0.71 ± 0.13 |
G × T: 0.08 |
| MHC IIx mRNA |
Group: 0.42 |
||
| Day 0 |
0.66 ± 0.14 |
0.65 ± 0.15 |
Time: 0.98 |
| Day 50 |
0.62 ± 0.07 |
0.69 ± 0.14 |
G × T: 0.10 |
|
Values are expressed as means ± SD. AA: Arachidonic acid, PLA: placebo, INT: integrated density units, MHC: myosin heavy chain. aSignificant within-group difference from baseline values, p < 0.05. bSignificant group × time (G × T) interaction, p < 0.05 | |||
Roberts et al. Journal of the International Society of Sports Nutrition 2007 4:21 doi:10.1186/1550-2783-4-21 |
|||